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Abstract
Background: Diabetes mellitus (DM) is associated with microvascular complications, such as diabetic retinopathy (DR). 
DR is one of the main causes of visual loss in individuals aged 20-64 years old. This study aims to investigate the 
independent associations between the stage of DR and a variety of possible risk factors, including years since DM 
diagnosis, HbA1c levels, the coexistence of hypertension, age and gender.
Findings: 120 patients were recruited in the Department of Internal Medicine, Veroia General Hospital, Veroia, Greece, 
and the DR stage was defined by an ophthalmologist. Afterwards, the DR association with the aforementioned factors 
was examined. Univariate and multivariate analysis (multivariate ordinal logistic regression) was performed. At the 
univariate analysis, there was a positive association between DR severity and age (Spearman's rho = 0.4869, p < 0.0001), 
years since DM diagnosis (Spearman's rho = 0.6877, p < 0.0001), HbA1c levels (Spearman's rho = 0.6315, p < 0.0001), 
history of hypertension (2.47 ± 1.37 vs. 0.50 ± 0.80 for patients without hypertension; p < 0.0001) and male sex (2.56 ± 
1.41 vs. 2.05 ± 1.45 for female patients; p = 0.045, MWW). All these factors, except for age, retained their statistical 
significance at the multivariate ordinal logistic model.
Conclusions: Years since DM diagnosis, hypertension, HbA1c levels and male sex are independently associated with 
severe DR. The effect of age seems to reflect a confounding association.
Background
Diabetes mellitus (DM) is associated with microvascular
complications, such as diabetic retinopathy (DR). DR is
one of the main causes of visual loss in individuals aged
20-64 years old [1] and is present in more than 77% of
patients with DM type 2 who survive for over 20 years
with the disease [2]. Many factors have been associated
w i t h  t h e  p r o g r e s s i o n  a n d  s e v e r i t y  o f  D R,  s u c h  a s  D M
duration [3,4], the control of serum glucose levels [4-6],
hypertension [4,7] or gender [4]. So far the most solid evi-
dence concerning the risk of DR pertains to chronic
hyperglycemia; interestingly, in insulin users with DM
type 2 (i.e., more severe cases), DR occurs in approxi-
mately 84.5% of patients after 15 years of the disease [6,8].
In this study, we aim to investigate the independent asso-
ciations between the stage of DR and a variety of risk fac-
tors, including years since DM diagnosis, HbA1c levels,
the coexistence of hypertension, age and gender.
Materials and methods
120 consecutive patients with type 2 DM (56 men and 64
women) participated in the study (age range: 42-89 years
old, median: 73.5 years). All consecutive patients were
recruited (during their routine follow-up) in the Depart-
ment of Internal Medicine, Veroia General Hospital,
Veroia, Greece, during the time period April 2009 to Sep-
tember 2009. A person was considered as known dia-
betic, if there was an informational letter from a
diabetologist. All participants underwent a comprehen-
sive dilated fundus examination to detect DR by indirect
ophthalmoscopy. DR was clinically graded in accordance
with the International Clinical Diabetic Retinopathy
guidelines [9]. The examined risk factors included demo-
graphic and clinical parameters. The demographic risk
factors studied were age and gender. The clinical factors * Correspondence: eirchat@yahoo.gr
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were the following: years since diagnosis of DM, HbA1c
levels and coexistence of hypertension.
The severity of DR was treated as an ordinal variable.
Specifically, 0: without findings, 1: mild non-proliferative
DR, 2: moderate non-priliferative DR, 3: severe non-pro-
liferative DR, 4: proliferative DR. Similarly, the variable
concerning years since diagnosis of DM was treated as an
ordinal variable (0: 0-5 years, 1: 5-10 years, 2: 10-15 years,
3: 15-20 years, 4: more than 20 years). Accordingly, HbA1c
levels were treated as an ordinal variable (0: <7%, 1: 7-
8.5%, 2: >8.5%).
The statistical analysis encompassed two steps: univari-
ate and multivariate analysis. At the univariate analysis,
the associations between the severity of DR and the study
variables (age, gender, HbA1c levels, years since diagnosis
of DM and hypertension) were appropriately evaluated
through non-parametric statistics (Mann-Whitney-Wil-
coxon test for independent samples, designated as MWW
for reasons of brevity, or Spearman's rank correlation
coefficient).
At the multivariate analysis, multivariate ordinal logis-
t i c  r e g r e s s i o n  w a s  p e r f o r m e d .  T h e  s e v e r i t y  o f  D R  w a s
treated as the dependent variable. The variables which
were proven significant at the univariate analysis were
entered as independent variables in the model; backward
selection of variables was performed so as to reach the
most parsimonious model. The satisfaction of the pro-
portionality-of-odds assumption was assessed with the
appropriate likelihood ratio test. Statistical analysis was
performed with STATA 8.0 statistical software (Stata
Corporation, College Station, TX, USA).
This study is in accordance with the Declaration of Hel-
sinki and has been approved by the local Ethics Commit-
tee. Written informed consent was obtained from all
patients. The authors declare no conflict of interest.
Results
At the univariate analysis, the severity of DR was posi-
tively associated with patients' age (Spearman's rho =
0.4869, p < 0.0001), years since DM diagnosis (Spear-
man's rho = 0.6877, p < 0.0001, Table 1), HbA1c levels
(Spearman's rho = 0.6315, p < 0.0001, Figure 1). Male
patients exhibited more advanced DR (2.56 ± 1.41 vs. 2.05
± 1.45 for female patients; p = 0.045, MWW). Patients
with coexisting hypertension presented with more severe
DR (2.47 ± 1.37 vs. 0.50 ± 0.80 for patients without hyper-
tension; p < 0.0001, MWW).
The results of the multivariate ordinal logistic regres-
sion are presented in Table 2. All variables, except for age,
retained their statistically significant associations with
the severity of DR at the multivariate approach.
Discussion
The duration of DM appears as a meaningful predictor
for DR and its severity [3,4,10] however, cases free of DR
are occasionally reported despite long duration of DM
[8]. Carefully examining the descriptive statistics of our
study sample, it is astonishing that 45.8% of patients who
were diagnosed with DM twenty or more years ago
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exhibit proliferative DR; on the contrary, 88.9% of
patients who have been diagnosed with DM since 0-5
years are free of DR.
The role of chronic hyperglycemia in the development
of DR has also been well established [4-6]. High HbA1c
levels are closely associated with severe DR in our study.
Decrease in HbA1c concentrations by 1% leads to an esti-
mated reduction of 30% in the risk of microvascular com-
plications [8].
Hypertension is an important risk factor for the onset
and progression of the disease, and in most studies it is an
independent risk factor for DR [4,6,7,10]. The UK Pro-
spective Diabetes Study (UKPDS) demonstrated that
blood pressure control is associated with a reduction in
DR incidence; the relative risk for DR is 1.5 concerning
systolic pressure between 125-139 mmHg and 2.8 for sys-
tolic pressure higher than 140 mm Hg [6].
In our study, male patients exhibited more advanced
DR; this finding seems distinct than that reported by pre-
vious studies, according to which male gender was related
with the presence of DR, but not its severity [4,10].
Concerning the role of age, it is worth commenting on
our study findings. Age was associated with the severity
of DR at the univariate analysis but lost its significance at
the multivariate model. Most probably, this reflects a
confounding effect of age, as older age and longer dura-
tion of DM are two factors closely associated with each
other. As a result, age does not seem to represent an inde-
pendent risk factor for severe DR.
A limitation of the present study was that DR grading
was based on fundoscopy and not on fundus photography
grading. This could have resulted in underestimation of
the prevalence and severity of DR. In addition, a consid-
erable limitation of this study pertains to the relatively
small sample size; nevertheless, the fact that the results
persisted at the multivariate approach points to the valid-
ity of the findings presented herein.
Conclusions
In conclusion, this study demonstrates that male gender,
coexistence of hypertension, years since diagnosis of DM
and HbA1c represent independent risk factors for severe
DR.
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Table 1: Detailed results on the association between the severity of DR and years since diagnosis of DM.
Duration of DM
Diabetic Retinopathy stage 0-5 years 5-10 years 10-15 years 15-20 years >20 years
n = 18 n = 10 n = 18 n = 26 n = 48
Without findings 88.9% (16/18) 40% (4/10) 16.7% (3/18)
Mild Non-Proliferative DR 11.1% (2/18) 40% (4/10) 27.8% (5/18) 6.3% (3/48)
Moderate Non-proliferative DR 20% (2/10) 22.2% (4/18) 11.5% (3/26) 22.9% (11/48)
Severe Non-proliferative DR 22.2% (4/18) 65.4% (17/
26)
25.0% (12/48)
Proliferative DR 11.1% (2/18) 23.1% (6/26) 45.8% (22/48)
Table 2: Results of the multivariate ordinal logistic regression
Variables Category or increment OR (95% CI) p-value
Gender Male vs. Female 3.57 (1.67-7.62) 0.001
Hypertension Yes vs. No 4.49 (1.15-17.49) 0.030
Years since diagnosis of DM 1 level increase 3.37 (2.34-4.85) <0.001
HbA1c 1 level increase 4.53 (2.11-9.72) <0.001Chatziralli et al. BMC Research Notes 2010, 3:153
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